Regular check ins, sensible dose pacing, and fast response to warning signs keep risks low while maintaining benefit
They set up a policy where compounders could work around FDA approval guidelines in cases of shortages." But right now, there is no shortage of GLP-1 medications, and because companies like Eli Lilly and Novo Nordisk have patents, patients are likely years away from FDA-approved generics
If you miss a dose, there are no immediate or severe consequences
If youre focused on optimizing your performance, improving recovery time, or addressing joint and tissue health, IGF-1 LR3 offers targeted support
Adding growth hormone releasing peptides creates a synergistic environment where both natural and exogenous IGF-1 work together